C4 Therapeutics, Inc. CCCC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

60/100

4/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour C4 Therapeutics, Inc. (CCCC), dont 30 achats et 20 ventes. Le total des achats d'initiés s'élève à $3.38M et le total des ventes d'initiés à $309.87K.

Les initiés notables ayant une activité récente comprennent Grogan Donna Roy, Anderson Kenneth Carl, Hirsch Andrew. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — CCCC

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-04-01	Grogan Donna Roy	Director	Attribution de RSU	5,370	$2.70	$14.5K	71,512
2026-04-01	Anderson Kenneth Carl	Director	Attribution de RSU	4,259	$2.70	$11.5K	68,230
2026-02-15	Hirsch Andrew	President & CEO	Retenue Fiscale RSU	9,057	$1.89	$17.12K	1,074,934
2026-02-14	Reyno Leonard	Chief Medical Officer	Retenue Fiscale RSU	16,579	$1.89	$31.33K	379,803
2026-02-14	Hirsch Andrew	President & CEO	Retenue Fiscale RSU	39,154	$1.89	$74K	1,083,991
2026-02-14	Schick Kelly	Chief People Officer	Retenue Fiscale RSU	7,269	$1.89	$13.74K	299,881
2026-02-14	Boyle Scott N	Chief Business Officer	Retenue Fiscale RSU	7,269	$1.89	$13.74K	298,801
2026-02-14	Adams Kendra	Chief Financial Officer	Retenue Fiscale RSU	15,381	$1.89	$29.07K	385,098
2026-02-14	Mossler Mark	Chief Accounting Officer	Retenue Fiscale RSU	3,268	$1.89	$6.18K	71,916
2026-02-14	Mahaney Paige	Chief Scientific Officer	Retenue Fiscale RSU	2,446	$1.89	$4.62K	336,910
2026-02-13	Reyno Leonard	Chief Medical Officer	Attribution de RSU	240,000	-	-	396,382
2026-02-13	Hirsch Andrew	President & CEO	Attribution de RSU	700,000	-	-	1,123,145
2026-02-13	Schick Kelly	Chief People Officer	Retenue Fiscale RSU	1,735	$1.89	$3.28K	307,150
2026-02-13	Boyle Scott N	Chief Business Officer	Retenue Fiscale RSU	1,735	$1.89	$3.28K	306,070
2026-02-13	Adams Kendra	Chief Financial Officer	Retenue Fiscale RSU	1,863	$1.89	$3.52K	400,479
2026-02-13	Mossler Mark	Chief Accounting Officer	Attribution de RSU	56,980	-	-	75,184
2026-02-13	Mahaney Paige	Chief Scientific Officer	Attribution de RSU	240,000	-	-	339,356
2026-01-16	Reyno Leonard	Chief Medical Officer	Vente Informative	10,000	$2.22	$22.2K	156,382
2026-01-02	Grogan Donna Roy	Director	Attribution de RSU	7,513	$1.93	$14.5K	66,142
2026-01-02	Anderson Kenneth Carl	Director	Attribution de RSU	5,958	$1.93	$11.5K	146,532
2025-10-28	Mahaney Paige	Chief Scientific Officer	Retenue Fiscale RSU	5,644	$2.58	$14.56K	99,356
2025-10-01	Grogan Donna Roy	Director	Attribution de RSU	6,740	$2.15	$14.49K	58,629
2025-10-01	Anderson Kenneth Carl	Director	Attribution de RSU	5,349	$2.15	$11.5K	140,574
2025-09-18	Adams Kendra	Chief Financial Officer	Retenue Fiscale RSU	2,775	$3.32	$9.21K	162,342
2025-07-10	Reyno Leonard	Chief Medical Officer	Retenue Fiscale RSU	7,382	$1.99	$14.69K	166,382
2025-07-10	Reyno Leonard	Chief Medical Officer	Exercice d'Options	15,325	-	-	173,764
2025-07-01	Grogan Donna Roy	Director	Attribution de RSU	9,609	$1.51	$14.51K	51,889
2025-07-01	Anderson Kenneth Carl	Director	Attribution de RSU	7,616	$1.51	$11.5K	135,225
2025-06-18	Hoerter Steven L.	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-06-18	Hughes Owen	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-06-18	Cooper Ronald Harold Wilfred	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-06-18	Koppikar Utpal	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-06-18	Grogan Donna Roy	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-06-18	Anderson Kenneth Carl	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-06-18	Bessen Laura	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-06-18	Fawell Stephen	Director	Attribution de RSU	35,500	$1.44	$51.12K	35,500
2025-04-01	Grogan Donna Roy	Director	Attribution de RSU	9,581	$1.44	$13.75K	42,280
2025-04-01	Anderson Kenneth Carl	Director	Attribution de RSU	7,841	$1.44	$11.25K	127,609
2025-02-18	Boyle Scott N	Chief Business Officer	Vente Informative	669	$3.15	$2.11K	107,805
2025-02-15	Hirsch Andrew	President & CEO	Retenue Fiscale RSU	9,370	$3.18	$29.8K	423,145
2025-02-14	Reyno Leonard	Chief Medical Officer	Attribution de RSU	130,600	$3.18	$415.31K	130,600
2025-02-14	Hirsch Andrew	President & CEO	Attribution de RSU	335,300	$3.18	$1.07M	335,300
2025-02-14	Siegel Jolie	Chief Legal Officer	Attribution de RSU	84,700	$3.18	$269.35K	84,700
2025-02-14	Schick Kelly	Chief People Officer	Attribution de RSU	84,700	$3.18	$269.35K	84,700
2025-02-14	Boyle Scott N	Chief Business Officer	Attribution de RSU	84,700	$3.18	$269.35K	84,700
2025-02-14	Adams Kendra	Chief Financial Officer	Attribution de RSU	130,600	$3.18	$415.31K	130,600
2025-02-14	Mossler Mark	Chief Accounting Officer	Retenue Fiscale RSU	1,586	$3.18	$5.04K	18,204
2025-02-14	Mahaney Paige	Chief Scientific Officer	Attribution de RSU	42,400	$3.18	$134.83K	42,400
2025-02-13	Siegel Jolie	Chief Legal Officer	Retenue Fiscale RSU	2,135	$3.20	$6.83K	54,353
2025-02-13	Schick Kelly	Chief People Officer	Retenue Fiscale RSU	1,735	$3.20	$5.55K	54,753

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration